fda glp-1 warning letters october 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA & Healthcare Regulatory Resource

Further research of in vivo and in vitro treated hepatocytes and liver fractions would complement our findings

If an athlete is prescribed a GLP-1 by a doctor to manage Type 2 diabetes, its important to be aware of the potential for Relative Energy Deficiency in Sport (REDs) due to under-fueling, so your athlete should be working with their doctor and other professionals to determine appropriate fueling and training while using the medication.

Patients should start with a low dose and increase gradually under medical supervision to minimize side effects

The information provided here is a research-reference summary only